Blood Cancer
Showing 65–71 of 71 results
-
XALKORI (crizotinib) capsules
Read more -
XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018
Read more -
YERVOY (ipilimumab) injection, for intravenous use. Initial U.S. Approval: 2011
Read more -
ZELBORAF (vemurafenib) tablet. FDA-Approved
Read more -
ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014
Read more -
ZYNLONTA (loncastuximab tesirine-lpyl) for injection
Read more -
ZYNYZ (retifanlimab-dlwr) injection
Read more
